Suzanne Topalian

Professor

1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Suzanne Topalian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Melanoma Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Melanoma-Specific Antigens Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Nghiem, P., Bhatia, S., Lipson, E., Sharfman, W., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., Boulmay, B. C., Riker, A. I., Burgess, M. A., Hanks, B. A., Olencki, T., Margolin, K., Lundgren, L. M., Soni, A., Ramchurren, N., Church, C. & 11 others, Park, S. Y., Shinohara, M. M., Salim, B., Taube, J. M., Bird, S. R., Ibrahim, N., Fling, S. P., Moreno, B. H., Sharon, E., Cheever, M. A. & Topalian, S., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 693-702 10 p.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Disease-Free Survival
Survival
Neoplasms
Merkel cell polyomavirus

Five-Year Survival and Correlates among Patients with Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated with Nivolumab

Topalian, S., Hodi, F. S., Brahmer, J., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Sosman, J. A., Atkins, M. B., Leming, P. D., Spigel, D. R., Antonia, S. J., Drilon, A., Wolchok, J. D., Carvajal, R. D., McHenry, M. B., Hosein, F., Harbison, C. T., Grosso, J. F. & Sznol, M., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Non-Small Cell Lung Carcinoma
Melanoma
Survival
Odds Ratio

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Naumann, R. W., Hollebecque, A., Meyer, T., Devlin, M. J., Oaknin, A., Kerger, J., López-Picazo, J. M., Machiels, J. P., Delord, J. P., Evans, T. R. J., Boni, V., Calvo, E., Topalian, S. L., Chen, T., Soumaoro, I., Li, B., Gu, J., Zwirtes, R. & Moore, K. N., Nov 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 31, p. 2825-2834 10 p.

Research output: Contribution to journalArticle

Open Access
Carcinoma
Safety
Vaginal Neoplasms
Vulvar Neoplasms
Uterine Cervical Neoplasms

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy

Miller, N. J., Church, C. D., Fling, S. P., Kulikauskas, R., Ramchurren, N., Shinohara, M. M., Kluger, H. M., Bhatia, S., Lundgren, L., Cheever, M. A., Topalian, S. & Nghiem, P., Nov 27 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 131.

Research output: Contribution to journalArticle

Merkel cell polyomavirus
Merkel Cell Carcinoma
T-Lymphocytes
Viruses
Neoplasms

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab 11 Medical and Health Sciences 1107 Immunology

Giraldo, N. A., Nguyen, P., Engle, E. L., Kaunitz, G. J., Cottrell, T. R., Berry, S., Green, B., Soni, A., Cuda, J. D., Stein, J. E., Sunshine, J. C., Succaria, F., Xu, H., Ogurtsova, A., Danilova, L. V., Church, C. D., Miller, N. J., Fling, S., Lundgren, L., Ramchurren, N. & 7 others, Yearley, J. H., Lipson, E., Cheever, M., Anders, R. A., Nghiem, P. T., Topalian, S. & Taube, J. M., Oct 1 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 99.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Allergy and Immunology
Health
Cell Count
pembrolizumab